Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Net Asset Momentum
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited net asset momentum. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) recorded a net asset momentum of 6.1% as of December 2025, with net assets of €40.08 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Guangzhou Baiyunshan Pharmaceutical Hold capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Net asset momentum of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +6.1%, with net assets of €40.08 Billion EUR as of December 2025. See Guangzhou Baiyunshan Pharmaceutical Hold shareholders equity for net asset value and shareholders' equity analysis.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Net Asset Momentum by Year (2013–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited net asset momentum by year from 2013 to 2025. The table below shows the complete annual net asset history for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see GU5 market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €40.08 Billion | €84.51 Billion | €44.43 Billion | ▲ +6.1% |
| 2024 | €37.77 Billion | €81.68 Billion | €43.91 Billion | ▲ +3.0% |
| 2023 | €36.68 Billion | €78.59 Billion | €41.91 Billion | ▲ +9.0% |
| 2022 | €33.64 Billion | €74.67 Billion | €41.03 Billion | ▲ +7.4% |
| 2021 | €31.33 Billion | €66.12 Billion | €34.79 Billion | ▲ +11.1% |
| 2020 | €28.21 Billion | €59.76 Billion | €31.55 Billion | ▲ +8.5% |
| 2019 | €25.99 Billion | €56.89 Billion | €30.90 Billion | ▲ +12.3% |
| 2018 | €23.14 Billion | €51.48 Billion | €28.34 Billion | ▲ +20.1% |
| 2017 | €19.26 Billion | €28.31 Billion | €9.05 Billion | ▲ +9.1% |
| 2016 | €17.65 Billion | €25.90 Billion | €8.24 Billion | ▲ +103.3% |
| 2015 | €8.68 Billion | €15.87 Billion | €7.19 Billion | ▲ +9.6% |
| 2014 | €7.92 Billion | €14.27 Billion | €6.34 Billion | ▲ +12.8% |
| 2013 | €7.02 Billion | €12.25 Billion | €5.23 Billion | — |